2008
DOI: 10.1007/s00772-008-0586-8
|View full text |Cite
|
Sign up to set email alerts
|

Temporäre Implantate für die endovaskuläre Applikation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2014
2014
2018
2018

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 30 publications
0
2
0
Order By: Relevance
“…pigs). 253,254 A variant of absorbable drug-releasing stents based on polymers are the so-called balloon-expandable bre-based stents, which can be composed of different polymers and blends of polymers (e.g. PLLA, polydioxanone (PDO), poly-glycolide-co-3-caprolactone (PGCL), etc.).…”
Section: Coronary Stentsmentioning
confidence: 99%
See 1 more Smart Citation
“…pigs). 253,254 A variant of absorbable drug-releasing stents based on polymers are the so-called balloon-expandable bre-based stents, which can be composed of different polymers and blends of polymers (e.g. PLLA, polydioxanone (PDO), poly-glycolide-co-3-caprolactone (PGCL), etc.).…”
Section: Coronary Stentsmentioning
confidence: 99%
“…PLLA, polydioxanone (PDO), poly-glycolide-co-3-caprolactone (PGCL), etc.). [254][255][256][257] Abbott Vascular developed the absorbable balloonexpandable stent BVS®, which is based on PDLLA and is currently studied in 30 clinical patients. This absorbable drugreleasing stent can keep a sustained release of everolimus over 120 days.…”
Section: Coronary Stentsmentioning
confidence: 99%